Abstract
The "gold standard" of the prevention of atrial fibrillation related thromboembolic events is anticoagulation therapy with oral vitamin K antagonists. A certain proportion of high-risk patients with atrial fibrillation are not receiving effective antithrombotic therapy because of problems associated with its use. Resolution of subsequent left atrial appendage thrombi is quite a great challenge in patients who are not tolerating "standard" antithrombotic drugs. According to the knowledge of the authors, this is the first report of a patient with non-valvular persistent atrial fibrillation and high stroke risk, who was intolerant to "standard" anticoagulant therapy and had persistent left atrial appendage thrombi following the use of a wide variety of "standard" anticoagulants. Successful resolution of left atrial appendage thrombi with dabigatran and successful percutaneous left atrial appendage closure were performed in this case. Orv. Hetil., 2013, 154, 262-265.
| Original language | Hungarian |
|---|---|
| Pages (from-to) | 262-265 |
| Number of pages | 4 |
| Journal | Orvosi Hetilap |
| Volume | 154 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 2013 |
Fingerprint
Keywords
- atrial fibrillation
- dabigatran
- left atrial appendage thrombi
- percutaneous left atrial appendage closure
ASJC Scopus subject areas
- Medicine(all)
Cite this
Percutan bal pitvari fülcsezárás dabigatrannal való fülcsethrombus feloldását követoen. / Kis, Zsuzsanna; Földesi, Csaba; Pál, Mátyás; Som, Zoltán; Csillik, Andrea; Ábrahám, Pál; Temesvári, András; Fontos, Géza; Szatmári, A.; Andréka, P.; Kardos, A.
In: Orvosi Hetilap, Vol. 154, No. 7, 2013, p. 262-265.Research output: Article
}
TY - JOUR
T1 - Percutan bal pitvari fülcsezárás dabigatrannal való fülcsethrombus feloldását követoen
AU - Kis, Zsuzsanna
AU - Földesi, Csaba
AU - Pál, Mátyás
AU - Som, Zoltán
AU - Csillik, Andrea
AU - Ábrahám, Pál
AU - Temesvári, András
AU - Fontos, Géza
AU - Szatmári, A.
AU - Andréka, P.
AU - Kardos, A.
PY - 2013
Y1 - 2013
N2 - The "gold standard" of the prevention of atrial fibrillation related thromboembolic events is anticoagulation therapy with oral vitamin K antagonists. A certain proportion of high-risk patients with atrial fibrillation are not receiving effective antithrombotic therapy because of problems associated with its use. Resolution of subsequent left atrial appendage thrombi is quite a great challenge in patients who are not tolerating "standard" antithrombotic drugs. According to the knowledge of the authors, this is the first report of a patient with non-valvular persistent atrial fibrillation and high stroke risk, who was intolerant to "standard" anticoagulant therapy and had persistent left atrial appendage thrombi following the use of a wide variety of "standard" anticoagulants. Successful resolution of left atrial appendage thrombi with dabigatran and successful percutaneous left atrial appendage closure were performed in this case. Orv. Hetil., 2013, 154, 262-265.
AB - The "gold standard" of the prevention of atrial fibrillation related thromboembolic events is anticoagulation therapy with oral vitamin K antagonists. A certain proportion of high-risk patients with atrial fibrillation are not receiving effective antithrombotic therapy because of problems associated with its use. Resolution of subsequent left atrial appendage thrombi is quite a great challenge in patients who are not tolerating "standard" antithrombotic drugs. According to the knowledge of the authors, this is the first report of a patient with non-valvular persistent atrial fibrillation and high stroke risk, who was intolerant to "standard" anticoagulant therapy and had persistent left atrial appendage thrombi following the use of a wide variety of "standard" anticoagulants. Successful resolution of left atrial appendage thrombi with dabigatran and successful percutaneous left atrial appendage closure were performed in this case. Orv. Hetil., 2013, 154, 262-265.
KW - atrial fibrillation
KW - dabigatran
KW - left atrial appendage thrombi
KW - percutaneous left atrial appendage closure
UR - http://www.scopus.com/inward/record.url?scp=84873640685&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873640685&partnerID=8YFLogxK
U2 - 10.1556/OH.2013.29550
DO - 10.1556/OH.2013.29550
M3 - Article
C2 - 23395790
AN - SCOPUS:84873640685
VL - 154
SP - 262
EP - 265
JO - Orvosi Hetilap
JF - Orvosi Hetilap
SN - 0030-6002
IS - 7
ER -